Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 46 recruiting now full pipeline #122 of 28,707 conditions

Opioid Use: full-pipeline trial registry

46 of 106 indexed Opioid Use trials are currently recruiting.

Corpus placement: #122 of 28,707 conditions by registered trial count.

106 US clinical trials · 46 currently recruiting · #122 of 28,707 conditions by registered trial count

Opioid Use: 106 US clinical trials tracked, 46 recruiting.

Opioid Use is the subject of 106 registered US clinical trials on ClinicalTrials.gov, 46 of them currently open to new participants. 20 are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most active sponsor is Hospital for Special Surgery, New York, running 7 of these trials.

Enrollment posture brief

Registry condition opioid-use

OPEN 46 | RECR 43% | LATE 20 | EARLY 14 | RANK #122 | SPON 7

Nearest open-share peer: Healthy Volunteer (43% recruiting · 113 trials)

Breast Carcinoma58.9%Non-Hodgkin Lymphoma54.2%Cognitive Impairment43.4%Opioid Use (this)43%Crohn's Disease34.9%
Open-enrollment share among volume-matched conditions near Opioid Use

Opioid Use lists 46 open slots (43% of 106 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Opioid Use on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Opioid Use is recruiting above its size-band peers.

    46 of 106 indexed trials (43.4%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Opioid Use trials is spread across many organizations.

    Hospital for Special Surgery, New York accounts for 7 of 106 trials (6.6%). 69 distinct sponsors appear on at least one study for this condition label.

  3. Typical Opioid Use enrolment sits around 144 participants.

    Median target enrolment is 144 among the 106 trials that report a genuine target (sentinel values excluded). 38 of those (35.8%) plan for fewer than 100 participants.

  4. Opioid Use research is mostly interventional.

    95 interventional and 11 observational studies make up this index (89.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 16Phase 28Phase 38Phase 412

Open and recent trials

106 total, page 2 of 3

ACTIVE NOT RECRUITING 250 participants

Adaptations of the Brain in Chronic Pain With Opioid Exposure I

Northwestern University

NCT05203770

ACTIVE NOT RECRUITING NA 219 participants

Trauma Intervention to Optimize PrEP Among Women Who Inject Drugs

Drexel University

NCT05192434

ACTIVE NOT RECRUITING NA 163 participants

Patient Utilization of Opioid Destruction Bags in the Post-op Period

University of Nebraska

NCT05875857

ACTIVE NOT RECRUITING NA 120 participants

SLeep and OPioid UsE in Patients Undergoing Total Knee Arthroplasty

Scripps Health

NCT04247646

ACTIVE NOT RECRUITING NA 120 participants

Reduced Opioid Prescription After Laparoscopic Hysterectomy

Johns Hopkins University

NCT05548582

ACTIVE NOT RECRUITING Phase 4 97 participants

Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial

University of Missouri, Kansas City

NCT04680221

ACTIVE NOT RECRUITING NA 74 participants

ENDOblock: Bilateral Superficial Cervical Blocks With Local Wound Infiltration in Thyroid Surgery

University of California, Davis

NCT05805423

ACTIVE NOT RECRUITING Phase 2 60 participants

Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure

Northwestern University

NCT05463367

ACTIVE NOT RECRUITING Phase 1 50 participants

A Prospective Randomized Double Blind Trial to Assess the Effect of a Single Preoperative Dose of Gabapentin on Postoperative Opioid Consumption in Patients Undergoing Rhinoplasty

Ohio State University

NCT03498261

ACTIVE NOT RECRUITING Phase 2 40 participants

Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)

Brigham and Women's Hospital

NCT04895306

ACTIVE NOT RECRUITING Early Phase 1 26 participants

Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls

University of Pennsylvania

NCT04401917

COMPLETED 15,438,284 participants

PCORnet Opioid Surveillance Study

Louisiana Public Health Institute

NCT03743493

COMPLETED 30,000 participants

A Difference-In-Differences Analysis of New Persistent Opioid Use After Surgery

University of Michigan

NCT04805229

COMPLETED NA 26,562 participants

Increasing Implementation of Post-Operative Opioid Prescribing Guidelines

University of Pennsylvania

NCT05358522

COMPLETED 5,411 participants

Comparing State Payer Strategies to Prevent Unsafe Opioid Prescribing

University of Washington

NCT03932799

COMPLETED NA 948 participants

Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients

Weill Medical College of Cornell University

NCT03377855

COMPLETED NA 712 participants

Evaluation of an Interactive Opioid Risk Education Program (STOMP) for Parents

University of Michigan

NCT03287622

COMPLETED NA 631 participants

PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Opioid-Naive Population

University of Minnesota

NCT04601493

COMPLETED NA 499 participants

Safely Disposing of Surplus Prescription Opioids

Johns Hopkins University

NCT03855241

COMPLETED NA 498 participants

Leveraging Social Networks to Increase COVID-19 Testing Uptake

New York State Psychiatric Institute

NCT04873401

COMPLETED 494 participants

Postpartum Opioid Prescribing Patterns and Patient Utilization

Northwestern University

NCT03030742

COMPLETED NA 484 participants

Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery

Hospital for Special Surgery, New York

NCT05384860

COMPLETED NA 350 participants

No Opioids PrescrIptions On Discharge After Surgery

Albany Medical College

NCT04469868

COMPLETED NA 270 participants

Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain

Vireo Health

NCT04495725

COMPLETED 257 participants

MEMO-Medical Marijuana and Opioids Study

Albert Einstein College of Medicine

NCT03268551

COMPLETED NA 240 participants

Opioid Use After Thyroid and Parathyroid Surgeries

The Methodist Hospital Research Institute

NCT04955444

COMPLETED 223 participants

A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries

St. Louis University

NCT03422211

COMPLETED NA 196 participants

Discharge Opioid Education to Decrease Opioid Use After Cesarean

Vanderbilt University Medical Center

NCT03678870

COMPLETED NA 190 participants

Opioid Prescribing After Cesarean Delivery

Vanderbilt University Medical Center

NCT03168425

COMPLETED NA 174 participants

Expectations and Pain Control Advancement In surgeRy: The REPAIR Trial

University of New Mexi

NCT03726476

COMPLETED Phase 4 154 participants

IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty

Hospital for Special Surgery, New York

NCT03020966

COMPLETED NA 144 participants

Effects of Hypnosis Therapy on Outcomes in Shoulder Replacement Therapy

Foundation for Orthopaedic Research and Education

NCT04889833

COMPLETED NA 125 participants

The Association Between Loneliness and Substance Use

University of Rochester

NCT04938492

COMPLETED NA 120 participants

Safe Options for ACL Recovery

Karen Derefinko, PhD

NCT04225468

COMPLETED Phase 2 118 participants

Perioperative Pregabalin in Ureteroscopy

University of Missouri-Columbia

NCT04122196

COMPLETED NA 115 participants

Suicide Prediction and Prevention for People at Risk for Opioid Use Disorder: Supplement to COMPUTE 2.0

HealthPartners Institute

NCT04939727

COMPLETED Phase 4 110 participants

Ketamine Versus Fentanyl for Surgical Abortions

University of Washington

NCT04871425

COMPLETED Early Phase 1 104 participants

Enhancing Prospective Thinking in Early Recovery (PARK)

Indiana University

NCT05908097

COMPLETED 98 participants

Perinatal Opioid Use

Medical University of South Carolina

NCT04049032

COMPLETED Phase 3 93 participants

Lidocaine Patches After Cesarean Section

Yale University

NCT04443569

COMPLETED Phase 4 86 participants

Opioid-Free Shoulder Arthroplasty

OrthoCarolina Research Institute

NCT03540030

COMPLETED NA 80 participants

Music Therapy in the Treatment of Perioperative Anxiety and Pain

University of Pittsburgh

NCT05263635

COMPLETED Phase 4 70 participants

Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty

NYU Langone Health

NCT03457116

COMPLETED Phase 4 70 participants

Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery

University Hospitals Cleveland Medical Center

NCT02509312

COMPLETED NA 61 participants

Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction

Ohio State University

NCT03791645

COMPLETED NA 48 participants

Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries?

John Yanik

NCT03570320

COMPLETED NA 42 participants

Opioid Education in Total Knee Arthroplasty

Hospital for Special Surgery, New York

NCT05593341

COMPLETED Early Phase 1 40 participants

Ultrasound Guided Serratus Anterior Plane Block in ED Patients With Rib Fractures

Rhode Island Hospital

NCT06299137

COMPLETED Phase 2 39 participants

Managing Opioid Related Sleep Apnea With Acetazolamide

University of California, San Diego

NCT06043830

COMPLETED NA 38 participants

Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain

Wake Forest University Health Sciences

NCT04156802

← Previous Page 2 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 8
Phase 3 8
Phase 4 12

Named interventions

Most-linked intervention names on Opioid Use records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
5 trials
Acetaminophen Drug
3 trials
Gabapentin Drug
2 trials
Normal saline Drug
2 trials
Acetazolamide Drug
2 trials
Ketorolac Drug
2 trials
Ketamine Drug
2 trials
Ibuprofen 600 mg Drug
2 trials

US sites by state

Facility locations filed on Opioid Use trials. A trial with sites in several states counts in each.

New York 20 trials
Pennsylvania 10 trials
Maryland 9 trials
Massachusetts 7 trials
California 7 trials
Missouri 6 trials
Illinois 6 trials
Texas 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Opioid Use page

106 registered trials, 46 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Opioid Use condition card totals 106 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.